Logo image of PDYN

PALLADYNE AI CORP (PDYN) Stock Fundamental Analysis

NASDAQ:PDYN - US80359A2050 - Common Stock

7.56 USD
-0.11 (-1.43%)
Last: 8/29/2025, 8:00:00 PM
7.56 USD
0 (0%)
After Hours: 8/29/2025, 8:00:00 PM
Fundamental Rating

3

Taking everything into account, PDYN scores 3 out of 10 in our fundamental rating. PDYN was compared to 128 industry peers in the Machinery industry. PDYN has a great financial health rating, but its profitability evaluates not so good. PDYN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PDYN has reported negative net income.
In the past year PDYN has reported a negative cash flow from operations.
PDYN Yearly Net Income VS EBIT VS OCF VS FCFPDYN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

PDYN's Return On Assets of -57.20% is on the low side compared to the rest of the industry. PDYN is outperformed by 90.63% of its industry peers.
PDYN's Return On Equity of -83.21% is on the low side compared to the rest of the industry. PDYN is outperformed by 86.72% of its industry peers.
Industry RankSector Rank
ROA -57.2%
ROE -83.21%
ROIC N/A
ROA(3y)-138.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PDYN Yearly ROA, ROE, ROICPDYN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

PDYN has a better Gross Margin (57.31%) than 96.09% of its industry peers.
In the last couple of years the Gross Margin of PDYN has grown nicely.
PDYN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y32.37%
GM growth 5YN/A
PDYN Yearly Profit, Operating, Gross MarginsPDYN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

7

2. Health

2.1 Basic Checks

PDYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PDYN has more shares outstanding
There is no outstanding debt for PDYN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PDYN Yearly Shares OutstandingPDYN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
PDYN Yearly Total Debt VS Total AssetsPDYN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

PDYN has an Altman-Z score of -0.94. This is a bad value and indicates that PDYN is not financially healthy and even has some risk of bankruptcy.
PDYN has a worse Altman-Z score (-0.94) than 82.81% of its industry peers.
PDYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.94
ROIC/WACCN/A
WACC10.35%
PDYN Yearly LT Debt VS Equity VS FCFPDYN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

PDYN has a Current Ratio of 17.12. This indicates that PDYN is financially healthy and has no problem in meeting its short term obligations.
PDYN has a better Current ratio (17.12) than 98.44% of its industry peers.
PDYN has a Quick Ratio of 17.10. This indicates that PDYN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 17.10, PDYN belongs to the best of the industry, outperforming 98.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 17.12
Quick Ratio 17.1
PDYN Yearly Current Assets VS Current LiabilitesPDYN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

PDYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.35%, which is quite impressive.
PDYN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.07%.
The Revenue has been growing by 15.33% on average over the past years. This is quite good.
EPS 1Y (TTM)42.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.75%
Revenue 1Y (TTM)-50.07%
Revenue growth 3Y15.33%
Revenue growth 5YN/A
Sales Q2Q%-62.59%

3.2 Future

The Earnings Per Share is expected to grow by 17.31% on average over the next years. This is quite good.
Based on estimates for the next years, PDYN will show a very strong growth in Revenue. The Revenue will grow by 21.50% on average per year.
EPS Next Y23.76%
EPS Next 2Y17.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-25.27%
Revenue Next 2Y21.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PDYN Yearly Revenue VS EstimatesPDYN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 5M 10M
PDYN Yearly EPS VS EstimatesPDYN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PDYN. In the last year negative earnings were reported.
Also next year PDYN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PDYN Price Earnings VS Forward Price EarningsPDYN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PDYN Per share dataPDYN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PDYN's earnings are expected to grow with 17.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.31%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PDYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PALLADYNE AI CORP

NASDAQ:PDYN (8/29/2025, 8:00:00 PM)

After market: 7.56 0 (0%)

7.56

-0.11 (-1.43%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-05 2025-08-05
Earnings (Next)11-11 2025-11-11
Inst Owners13.41%
Inst Owner ChangeN/A
Ins Owners27.24%
Ins Owner Change30.18%
Market Cap317.14M
Analysts82.86
Price Target15.3 (102.38%)
Short Float %22.33%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)8.13%
Min Revenue beat(2)-23.45%
Max Revenue beat(2)39.71%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 72.79
P/FCF N/A
P/OCF N/A
P/B 5.89
P/tB 5.89
EV/EBITDA N/A
EPS(TTM)-1.74
EYN/A
EPS(NY)-0.64
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS0.1
BVpS1.28
TBVpS1.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -57.2%
ROE -83.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.31%
FCFM N/A
ROA(3y)-138.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y32.37%
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.83%
Cap/Sales 3.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.12
Quick Ratio 17.1
Altman-Z -0.94
F-Score5
WACC10.35%
ROIC/WACCN/A
Cap/Depr(3y)30.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.8%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.75%
EPS Next Y23.76%
EPS Next 2Y17.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.07%
Revenue growth 3Y15.33%
Revenue growth 5YN/A
Sales Q2Q%-62.59%
Revenue Next Year-25.27%
Revenue Next 2Y21.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.54%
EBIT Next 3Y90.23%
EBIT Next 5Y65.6%
FCF growth 1Y70.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.47%
OCF growth 3YN/A
OCF growth 5YN/A